Immune cell boost may help islet transplants work better in type 1 diabetes
NCT ID NCT05973734
First seen Jun 16, 2026 · Last updated Jun 19, 2026 · Updated 1 time
Summary
This early-phase study tests whether adding special immune cells to a standard islet transplant can help people with severe type 1 diabetes better control their blood sugar. Participants will receive either their own regulatory T cells or donor bone marrow cells along with the transplant. The study involves 24 adults aged 18 to 70 and focuses on safety and feasibility.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Stanford University
Palo Alto, California, 94305, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.